Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• Những tác giả chính: Qi-An Chen (Tác giả), Wei-Hao Lin (Tác giả), Xiao-Xiang Zhou (Tác giả), Zheng Cao (Tác giả), Xiao-Li Feng (Tác giả), Yi-Bo Gao (Tác giả), Jie He (Tác giả)
• Định dạng: Sách
• Được phát hành: Elsevier, 2024-02-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...